Fresh analysis indicates that people who come off blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who end conventional diet and exercise programs.
Research printed in a major medical journal demonstrates that while obese individuals often shed substantial amounts of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals using these medications need to be cognizant of the danger of quick rebound weight gain when the medication ends," cautioned expert Dr. Susan Jebb.
That rate of regain suggests a return to starting weight within about one and a half years.
Comparing Approaches
The analysis, which looked at 37 of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with conventional dieting.
Scientists note that individuals who shed pounds through diet and exercise usually experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
The Reason for the Quick Rebound
Nutrition scientists propose the mode of action of the jabs is key to understanding the amplified weight return.
These medications imitate a natural hormone called GLP-1, which moderates hunger.
"Artificially providing the hormone concentrations far above than normal may cause the body to generate a reduced amount of its own natural GLP-1, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.
"Stopping of this GLP-1 'fix' leads to appetite is no longer kept in check, making binge eating much more probable."
An Ongoing Condition?
Health authorities suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Many experts contend that, due to the significant potential of relapse, the treatment should be considered life-long.
This view is reinforced by pharmaceutical companies, who state that the results "highlight the chronic nature of excess weight," comparing it to managing conditions like hypertension.
Patient Testimonies
Individuals who have discontinued the medication describe a powerful resurgence of appetite.
"I experienced a trigger that goes on and I was suddenly starving," recalled one woman.
This difficulty is compounded if users have not developed permanent dietary or behavioural modifications during therapy.
Significant Adoption
Recent estimates suggest that millions of adults in the UK have used these injections in the past year, with demand continuing to grow.
- Use is more common among women than men.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a magic solution and long-term success hinges on ongoing behavioural management.
